ctDNA-guided Selection of Adjuvant Chemotherapy Regimens for Elderly Colon Cancer Patients After Surgery: A Single-center, Randomized, Controlled Study

NCT06609551 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

312

Enrollment

OTHER

Sponsor class

Conditions

Colon Cancer
Colon Cancer (Stage II &Amp;Amp;Amp; III)

Interventions

DRUG: 6-month adjuvant chemotherapy with 5-FU monotherapy
DRUG: XELOX intensive treatment group

Sponsor

Zhejiang Cancer Hospital